Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Urol Oncol. 2019 Mar 20;37(6):356.e1–356.e7. doi: 10.1016/j.urolonc.2019.02.015

Table 5.

Oncologic Outcomes

Operation sPN mPN Total p value
n=35 n=74 n=109
Post-Op Metastases (%) 3 (8.6) 3 (4.1) 6(5.0) p=0.4
Mean* Time to Metastasis (95% CI), mo 173.6 (144.5, 202.4) 204.3 (186.8, 221.7) 199.4 (183.5, 215.4) p=0.3
Median Follow Up Time (IQR), mo 35.9 (71.1) 42.5 (76.2) 40.1 (74.5) p=0.5

Metastases were pathologic diagnoses. Cytoreductive procedures were excluded.

*

Median time to metastasis not reached